The effect of intrauterine devices, the stainless steel ring, the copper T220, and releasing levonorgestrel, on the bleeding profile and the morphological structure of the human endometrium--a comparative study of three IUDs. A morphometric study of 96 cases
- PMID:2510968
- DOI: 10.1016/0010-7824(89)90050-4
The effect of intrauterine devices, the stainless steel ring, the copper T220, and releasing levonorgestrel, on the bleeding profile and the morphological structure of the human endometrium--a comparative study of three IUDs. A morphometric study of 96 cases
Abstract
Thirty-four women using the stainless steel ring (SS), 43 women using the Copper T220 (TCu), and 19 women using levonorgestrel-releasing intrauterine devices (LNG) were admitted to the study. The light microscopic biopsy material was subjected to morphometric studies including 8 indices of endometrial activity before (Control) and after 24 months of exposure to the SS and TCu device and 3-10 months of exposure to the LNG device. The women were grouped into subjects with and without intermenstrual and prolonged bleeding. The results revealed that there were highly significant differences between the IUDs at the endometrial level as displayed by morphometry. However, the difference between bleeders and non-bleeders was not significant in any of the three types of IUDs. Although the mode of action of these IUDs at the endometrial level is different, the mechanism responsible for the irregular endometrial bleeding needs to be further investigated.
Similar articles
- The effect of intrauterine devices (stainless steel ring, copper-T220 and levonorgestrel) on the DNA content in isolated human endometrial cells.Zhu PD, Luo HZ, Cheng J, Xu RH, Liu YF, Zheng WM, Song GY, Chen JH, Zhou ZH, Wu YM, et al.Zhu PD, et al.Contraception. 1989 Nov;40(5):591-604. doi: 10.1016/0010-7824(89)90131-5.Contraception. 1989.PMID:2515028
- Ultrastructural comparative study on endometrium of Chinese women using intrauterine devices of stainless steel ring, copper T220, and releasing levonorgestrel: morphometry of microvessels.Wang JD, Zhu PD, Cheng J, Luo HZ, Xu RH, Hu WW.Wang JD, et al.Contraception. 1990 Apr;41(4):389-97. doi: 10.1016/0010-7824(90)90038-w.Contraception. 1990.PMID:2335103
- The presence of mast cells in the human endometrium pre- and post-insertion of intrauterine devices.Yin M, Zhu P, Luo H, Xu R.Yin M, et al.Contraception. 1993 Sep;48(3):245-54. doi: 10.1016/0010-7824(93)90143-u.Contraception. 1993.PMID:8222654Clinical Trial.
- Endometrial morphological changes in IUD users: a review.Sheppard BL.Sheppard BL.Contraception. 1987 Jul;36(1):1-10. doi: 10.1016/0010-7824(87)90057-6.Contraception. 1987.PMID:3117492Review.
- An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.Chi IC.Chi IC.Contraception. 1991 Dec;44(6):573-88. doi: 10.1016/0010-7824(91)90078-t.Contraception. 1991.PMID:1773615Review.
Cited by
- Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.French R, Van Vliet H, Cowan F, Mansour D, Morris S, Hughes D, Robinson A, Proctor T, Summerbell C, Logan S, Helmerhorst F, Guillebaud J.French R, et al.Cochrane Database Syst Rev. 2004;2004(3):CD001776. doi: 10.1002/14651858.CD001776.pub2.Cochrane Database Syst Rev. 2004.PMID:15266453Free PMC article.Review.
- Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS.Bednarek PH, Jensen JT.Bednarek PH, et al.Int J Womens Health. 2010 Aug 9;1:45-58. doi: 10.2147/ijwh.s4350.Int J Womens Health. 2010.PMID:21072274Free PMC article.
- A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.Sturridge F, Guillebaud J.Sturridge F, et al.Drug Saf. 1996 Dec;15(6):430-40. doi: 10.2165/00002018-199615060-00006.Drug Saf. 1996.PMID:8968696Review.
- The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.Kaunitz AM, Inki P.Kaunitz AM, et al.Drugs. 2012 Jan 22;72(2):193-215. doi: 10.2165/11598960-000000000-00000.Drugs. 2012.PMID:22268392Review.
- Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.Backman T.Backman T.Drug Saf. 2004;27(15):1185-204. doi: 10.2165/00002018-200427150-00003.Drug Saf. 2004.PMID:15588115
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical